NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Editor’s Note June 5, 2012

This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they missed. OneMedRadio brings you management interviews with Synthetic Biologics, Pluristem, Nanoviricides, and Biovest. We also interviewed Gerry DiFiore, partner at Reed Smith, sponsor of our recent OneMedForum NY 2012 kick off reception in New York City. Gearing up for our third annual trans-Atlantic conference in New York, we have many new interesting companies slated to present. Stay tuned for feature articles highlighting these disruptive technologies.  And don't forget to register to be present July 12th at OneMedForum New York. Sincerely, Brett Johnson  

To continue reading, please Login or Join